Contents

Reviews on Recent Clinical Trials, Volume 2 - Number 2

Editorial [Hot Topic: Novel Kinase Inhibitors in Cancer Therapy (Guest Editors: Ezra E.W. Cohen and Nikolai G. Rainov)]

, 2(2): 85 - 86

Nikolai G. Rainov and Ezra E. W. Cohen


DOI: 10.2174/157488707780599339




Receptor Tyrosine Kinases as Therapeutic Targets in Malignant Glioma

, 2(2): 87 - 101

H. Ren, B. F. Yang and Nikolai G. Rainov


DOI: 10.2174/157488707780599384




Clinical Development of mTOR Inhibitors: A Focus on Lymphoma

, 2(2): 103 - 110

Sonali M. Smith


DOI: 10.2174/157488707780599366




Targeting the Human Epidermal Growth Factor Receptor 2 (HER2) in the Treatment of Breast Cancer: Recent Advances and Future Directions

, 2(2): 111 - 116

Rita Nanda


DOI: 10.2174/157488707780599375




Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: A Review of Recent Clinical Trials

, 2(2): 117 - 120

Carrie B. Lee and Mark A. Socinski


DOI: 10.2174/157488707780599401




Therapeutic Strategies for Targeting BRAF in Human Cancer

, 2(2): 121 - 134

Christine A. Pratilas and David B. Solit


DOI: 10.2174/157488707780599393




Implications of FLT3 Mutations in the Therapy of Acute Myeloid Leukemia

, 2(2): 135 - 141

Ryan J. Mattison, Kelly R. Ostler, Frederick L. Locke and Lucy A. Godley


DOI: 10.2174/157488707780599320




Review of Clinic Trials: Agents Targeting c-Met

, 2(2): 143 - 147

Oyewale Abidoye, Nadh Murukurthy and Ravi Salgia


DOI: 10.2174/157488707780599357




New Treatment Concepts In Diffuse Large B-Cell Lymphomas (DLBL): Chemotherapy and Biological Therapy

, 2(2): 149 - 162

Jose Rodriguez and Antonio Gutierrez


DOI: 10.2174/157488707780599348




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science